Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC002985.3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | AC006386.1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | AC006486.9 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | AC009065.1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | AC009133.23 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | AC010642.1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | AC023908.1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | AC027682.1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | AC068533.7 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | AC104534.3 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |